Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    CELESTIAL
Show Display Options
Rank Status Study
1 Active, not recruiting Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Condition: Congestive Heart Failure
Intervention: Device: CRT Therapy - LV Lead Registry
2 Recruiting Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib
Condition: Hepatocellular Carcinoma
Interventions: Drug: Cabozantinib (XL184);   Drug: Placebo
3 Completed The Effect of Hibiscus Sabdariffa L. Tea on Blood Pressure
Condition: Hypertension
Intervention: Behavioral: herbal therapy/botanical therapy (Hibiscus sabdariffa)

Indicates status has not been verified in more than two years